Skip to main content

Table 4 Comparisons between ERK 2 genotypes and clinical characteristics, biochemical-hormonal parameters

From: The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis

 

PCOS-ERK 2

Control-ERK 2

Pa

Parameters

P-GG

P-GC

C-GG

C-GC

 

BMI

25,49 ± 3,88b

31,5 ± 5,38c,d

26,3 ± 6,25

27,29 ± 5,43

≤ 0.001

FGS

9,76 ± 3,04b,f

14,3 ± 6,52c,d

5,20 ± 1,67

8,36 ± 1,32

≤ 0.001

HOMA-IR

2,24 ± 1,55b

3,40 ± 1,97 c,d

1,76 ± 0,79

1,84 ± 1,47

≤ 0.001

CRP

11,16 ± 2,59f

12,03 ± 2,80c

5,39 ± 2,24g

10,67 ± 5,45

≤ 0.001

Total testesteron

0,72 ± 0,36f

0,75 ± 0,37c

0,48 ± 0,2

0,6 ± 0,18

≤ 0.001

Triglyceride

122 ± 53e,f

114,95 ± 46,03c,d

93,17 ± 40,87

86,81 ± 25,7

≤ 0.001

Total Cholesterol

191,52 ± 41,98f

192,7 ± 45,03c

164,87 ± 27

186,09 ± 35,4

≤ 0.001

LDL

113,31 ± 37,75

119,5 ± 44,28c

96,26 ± 23,8

111,27 ± 32,43

≤ 0.001

HDL

53,80 ± 10,51

50,23 ± 10,24d

51,12 ± 11,12

58,63 ± 11,39

≤ 0.001

  1. Data presented as Mean ± SD and p < 0.05 accepted as statistically significant
  2. a Groups were compared between P-GG,P-GC,C-GG and C-GC with; one-way ANOVA test
  3. p < 0.05 (P-GG vs P-GC); Tamhane test
  4. p < 0.05 (P-GC vs C-GG); Tamhane test
  5. p < 0.05 (P-GC vs C-GC); Tamhane test
  6. p < 0.05 (P-GG vs C-GC); Tamhane test
  7. p < 0.05 (P-GG vs C-GG); Tamhane test
  8. p < 0.05 (C-GG vs C-GC); Tamhane test
  9. P: PCOS (Polycystic Ovary Sydrome) Group
  10. C: Control Group